Article Information
History
- February 25, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jing Yu, MD*,1,2,3,
- Wen Ouyang, MD*,1,2,3,
- Melvin L.K. Chua, MBBS FRCR PhD‡,1,4,5,† and
- Conghua Xie, MD‡,1,2,3,†
- 1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China, 430071
- 2Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China, 430071
- 3Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China, 430071
- 4Division of Radiation Oncology, Division of Medical Sciences, National Cancer Centre Singapore
- 5Oncology Academic Programme, Duke-NUS Medical School,Singapore
- ↵†Correspondence to: Conghua Xie, MD, Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, People’s Republic of China.E-mail: chxie_65{at}whu.edu.cn; Tel: +86-27-67812607; Fax: +86-27-67812889, Dr Melvin L. K. Chua, Division of Radiation Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore 169610. E-mail: melvin.chua.l.k{at}singhealth.com.sg; Tel: +65-64368000.
Posted February 25, 2020.
